CoChat

Imaging synaptic density in depression

Open access
Holmes, Sophie E., Abdallah, Chadi, Esterlis, Irina · 2023 · Neuropsychopharmacology

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Abstract

Major depressive disorder is a prevalent and heterogeneous disorder with treatment resistance in at least 50% of individuals. Most of the initial studies focused on the monoamine system; however, recently other mechanisms have come under investigation. Specific to the current issue, studies show synaptic involvement in depression. Other articles in this issue report on reductions in synaptic density, dendritic spines, boutons and glia associated with stress and depression. Importantly, it appears that some drugs (e.g., ketamine) may lead to rapid synaptic restoration or synaptogenesis. Direct evidence for this comes from preclinical work. However, neuroimaging studies, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), have become useful in assessing these changes in vivo. Here, we describe the use of neuroimaging techniques in the evaluation of synaptic alterations associated with depression in humans, as well as measurement of synaptic restoration after administration of ketamine. Although more research is desired, use of these techniques widen our understanding of depression and move us further along the path to targeted and effective treatment for depression.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41386-022-01368-4

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 51 references

Research works printed but not linked: 1

  1. Abdallah C, Mason G, DellaGioia N, Sanacora G, Jiang L, Matuskey D, et al. mGluR5 and glutamate involvement in MDD: a multimodal imaging study. Biol Psychiatry. 2017;2:449–56.

Cited by

See all 39

Metadata

Authors
Holmes, S. E., Abdallah, C., & Esterlis, I.
Affiliations
  • Yale University (US)
  • Baylor College of Medicine (US)
Corresponding author
Esterlis, Irina
Venue
Neuropsychopharmacology
Published
2022-06-29
Volume
48
Issue
1
Pages
186-190
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W4283763677
Cited by
39
References
52
Citations by year
2026: 8 · 2025: 12 · 2024: 11 · 2023: 7 · 2022: 1
FWCI
1.11
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders
  • Veterans Affairs National Center for PTSD
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH104459)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
major depressive disorder, synaptic density, ketamine, synaptogenesis, dendritic spines, glia, stress, treatment-resistant depression, magnetic resonance imaging, positron emission tomography
MeSH terms
Depression, Depressive Disorder, Major, Major Depressive Disorder, Humans, Ketamine, Positron-Emission Tomography, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Imaging synaptic density in depression. https://app.cochat.ai/papers/10.1038/s41386-022-01368-4
The paper
Holmes, S. E., Abdallah, C., & Esterlis, I. (2023). Imaging synaptic density in depression. Neuropsychopharmacology. https://doi.org/10.1038/s41386-022-01368-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.